| Literature DB >> 26784224 |
Megan C Hallam1, Raylene A Reimer2,3.
Abstract
The Thrifty Phenotype Hypothesis proposes that the fetus takes cues from the maternal environment to predict its postnatal environment. A mismatch between the predicted and actual environments precipitates an increased risk of chronic disease. Our objective was to determine if, following a high fat, high sucrose (HFS) diet challenge in adulthood, re-matching offspring to their maternal gestational diet would improve metabolic health more so than if there was no previous exposure to that diet. Animals re-matched to a high prebiotic fiber diet (HF) had lower body weight and adiposity than animals re-matched to a high protein (HP) or control (C) diet and also had increased levels of the satiety hormones GLP-1 and PYY (p < 0.05). Control animals, whether maintained throughout the study on AIN-93M, or continued on HFS rather than reverting back to AIN-93M, did not differ from each other in body weight or adiposity. Overall, the HF diet was associated with the most beneficial metabolic phenotype (body fat, glucose control, satiety hormones). The HP diet, as per our previous work, had detrimental effects on body weight and adiposity. Findings in control rats suggest that the obesogenic potential of the powdered AIN-93 diet warrants investigation.Entities:
Keywords: dietary protein; fetal programming; maternal diet; obesity; prebiotics
Mesh:
Substances:
Year: 2016 PMID: 26784224 PMCID: PMC4728659 DOI: 10.3390/nu8010046
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Maintenance and HFS Diet Compositions.
| Ingredient (g/kg) | Control (AIN-93M) | High Protein | High Fiber | HFS |
|---|---|---|---|---|
| Cornstarch | 465.7 | 205.7 | 325.5 | 49.5 |
| Casein | 140.0 | 400.0 | 120.4 | 140.0 |
| Dyetrose | 155.0 | 155.0 | 133.0 | - |
| Sucrose | 100.0 | 100.0 | 86.0 | 510.0 |
| Soybean Oil | 40.0 | 40.0 | 34.4 | 100.0 |
| Lard | - | - | - | 100.0 |
| Alphacel | 50.0 | 50.0 | 43.0 | 50.0 |
| AIN-93M Mineral Mix | 35.0 | 35.0 | 30.1 | 35.0 |
| AIN-93-VX Vitamin Mix | 10.0 | 10.0 | 8.6 | 10.0 |
| 1.8 | 1.8 | 1.6 | 2.0 | |
| - | - | - | 3.0 | |
| Choline Bitartrate | 2.5 | 2.5 | 2.2 | 2.5 |
| Inulin | - | - | 107.6 | - |
| Oligofructose | - | - | 107.6 | - |
Figure 1Schematic of study design for Reference (A) and Experimental (B) groups.
Figure 2Body weight and weight gain of rats over the six week re-matching period following an eight week period of high fat, high sucrose diet consumption. Values are means ± SEM, n = 10 per group except n = 4 for group H. * represents a significant (p < 0.05) difference between HF1 and C1. ** represents a significant (p < 0.05) difference within HF1 between 23 and 28 weeks. For weight change, treatments with different letters are significantly different between diets (p < 0.05): superscripts x,y indicate significant difference between C1, HP1, HF1. There were no differences between R, H and C1.
Figure 3Energy intake (A), percent body fat (B), lean mass (C) and bone mineral density (D) at weeks 24 and 27 for all groups. Values are means ± SEM, n = 10 per group except n = 4 for group H. Treatments with different letters are significantly different between diets: superscripts x,y indicate significant difference between C1, HP1, HF1; superscripts a,b indicate significant difference between R, H and C1 (p < 0.05).
Physical characteristics of offspring at 28 weeks.
| Diet Group | ||||||
|---|---|---|---|---|---|---|
| Sex | HP1 | HF1 | C1 | R | H | |
| Liver (g) | M | 16.1 ± 0.5 | 15.5 ± 0.7 | 17.3 ± 0.7 | 18.8 ± 0.9 | 19.0 ± 1.0 |
| F | 9.5 ± 0.6 | 8.9 ± 0.4 | 9.8 ± 0.8 | 9.0 ± 1.2 | 10.2 ± 1.1 | |
| Stomach (g) | M | 2.7 ± 0.1 | 2.6 ± 0.1 | 2.8 ± 0.1 a | 3.3 ± 0.1 b | 3.1 ± 0.2 b |
| F | 2.0 ± 0.1 | 2.0 ± 0.1 | 1.9 ± 0.1 a | 1.9 ± 0.2 b | 2.4 ± 0.3 b | |
| Small Intestine Length (cm) | M | 130.5 ± 1.5 x | 143.8 ± 2.7 y | 125.7 ± 2.4 x,a | 134.8 ± 2.2 b | 133.8 ± 1.3 a,b |
| F | 115.0 ± 3.4 x | 122.8 ± 2.5 y | 116.8 ± 3.7 x,a | 104.6 ± 2.2 b | 122 ± 5.5 a,b | |
| Small Intestine Weight (g) | M | 8.1 ± 0.4 | 8.7 ± 0.4 | 7.9 ± 0.2 | 8.2 ± 0.24 | 8.6 ± 0.13 |
| F | 6.1 ± 0.4 | 6.1 ± 0.4 | 6.8 ± 0.3 | 5.4 ± 0.64 | 6.3 ± 0.41 | |
| Cecum (g) | M | 1.07 ± 0.1 x | 3.2 ± 0.3 y | 1.01 ± 0.1 x,a | 1.5 ± 0.04 b | 0.63 ± 0.36 a |
| F | 0.74 ± 0.06 x | 2.3 ± 0.3 y | 0.8 ± 0.1 x,a | 1.0 ± 0.19 b | 0.88 ± 0.29 a | |
| Colon Length (cm) | M | 23.5 ± 0.7 x | 26.1 ± 0.9 y | 21.6 ± 0.7 x | 21.1 ± 0.43 | 23.3 ± 0.85 |
| F | 19.6 ± 0.3 x | 24.8 ± 0.4 y | 20.0 ± 0.7 x | 16.4 ± 1.9 | 20.5 ± 1.3 | |
| Colon Weight (g) | M | 2.1 ± 0.1 y | 2.4 ± 0.2 z | 1.8 ± 0.1 x | 1.6 ± 0.05 | 1.9 ± 0.1 |
| F | 1.5 ± 0.1 y | 2.0 ± 0.1 z | 1.3 ± 0.05 x | 1.1 ± 0.13 | 1.3 ± 0.06 | |
| Kidneys (g) | M | 4.0 ± 0.1 y | 3.4 ± 0.1 x | 3.6 ± 0.1 x | 3.5 ± 0.1 | 3.8 ± 0.2 |
| F | 2.4 ± 0.1 y | 2.1 ± 0.1 x | 2.3 ± 0.1 x | 1.9 ± 0.2 | 2.4 ± 0.3 | |
| Nasoanal Length (cm) | M | 28.9 ± 0.16 | 28.6 ± 0.34 | 28.5 ± 0.19 | 28.4 ± 0.16 | 28.8 ± 0.32 |
| F | 24.0 ± 0.41 | 23.5 ± 0.19 | 24.0 ± 0.17 | 23.6 ± 0.27 | 23.8 ± 0.32 | |
HP1, offspring of high protein (HP) dams re-matched to HP in adulthood; HF1, offspring of high prebiotic fiber (HF) dams re-matched to HF in adulthood; C1, offspring of control dams re-matched to control in adulthood; R, reference group no high fat/sucrose (HFS) consumed; H, continued on HFS after other groups re-matched; M, male; F, female. Values are means ± SEM, n = 10 per group except n = 4 for group H. Values with different letters are significantly different from each other: superscripts x,y,z indicate significant difference between C1, HP1, HF1; superscripts a,b indicate significant difference between R, H and C1 (p < 0.05).
Fasting blood glucose, plasma satiety hormones, HOMA-IR and liver triglycerides in adult offspring re-matched to maternal diet.
| Diet Group | ||||||
|---|---|---|---|---|---|---|
| Sex | HP1 | HF1 | C1 | R | H | |
| Glucose (mmol/l) | M | 6.38 ± 0.29 | 5.59 ± 0.32 | 5.65 ± 0.28 b | 4.98 ± 0.08 a | 4.88 ± 0.45 a |
| F | 6.16 ± 0.54 | 5.88 ± 0.45 | 5.83 ± 0.34 b | 3.20 ± 0.67 a | 4.55 ± 0.17 a | |
| Insulin (pg/mL) | M | 2565 ± 443 x | 3312 ± 633 x | 5958 ± 731 y,b | 3022 ± 595 a | 1888 ± 150 a |
| F | 1880 ± 274 | 1321 ± 343 | 1692 ± 513 a | 1599 ± 394 a,b | 2375 ± 1133 a,b | |
| Amylin (pg/mL) | M | 56.4 ± 10.5 | 63.0 ± 5.7 | 75.0 ± 11.1 a | 43.1 ± 6.8 a | 418.6 ± 145.2 b |
| F | 52.8 ± 9.4 | 54.3 ± 4.8 | 52.2 ± 8.1 a,b | 37.3 ± 6.4 a,b | 51.5 ± 9.7 a | |
| Ghrelin (ng/mL) | M | 159.4 ± 36.8 | 235.1 ± 39.2 | 233.1 ± 39.7 | 266.8 ± 52.1 | 171.4 ± 32.1 |
| F | 246.1 ± 50.7 | 369.6 ± 47.7 | 344.7 ± 55.4 | 529.1 ± 74.4 | 402.7 ± 65.7 | |
| GIP (ng/mL) | M | 46.5 ± 8.3 | 47.8 ± 6.6 | 49.9 ± 6.3 | 49.9 ± 6.3 | 87.3 ± 14.0 |
| F | 33.4 ± 9.2 | 42.1 ± 3.2 | 41.6 ± 8.4 | 49.7 ± 5.3 | 34.9 ± 6.1 | |
| PYY (pg/mL) | M | 62.7 ± 7.5 x | 262.5 ± 43.2 y | 64.1 ± 4.4 x | 72.4 ± 6.3 | 54.0 ± 10.9 |
| F | 63.5 ± 8.9 x | 201.3 ± 35.1 y | 55.8 ± 5.0 x | 62.2 ± 13.6 | 36.1 ± 4.9 | |
| GLP-1 (pg/mL) | M | 6.0 ± 0.58 x | 8.4 ± 0.79 y | 7.22 ± 0.48 x,a,b | 6.5 ± 0.42 a,b | 5.4 ± 0.19 a,b |
| F | 6.36 ± 0.37 x | 8.54 ± 1.5 y | 4.45 ± 0.72 x,a | 6.4 ± 0.37 b | 4.82 ± 0.35 a,b | |
| Leptin (ng/mL) | M | 21.0 ± 4.2 y | 14.5 ± 2.2 x | 27.2 ± 2.5 y | 20.4 ± 1.9 | 18.4 ± 2.4 |
| F | 10.3 ± 1.6 y | 6.5 ± 1.0 x | 11.1 ± 2.1 y | 12.9 ± 1.4 | 11.3 ± 4.1 | |
| HOMA-IR | M | 20.2 ± 3.8 x | 19.0 ± 3.4 x | 35.9 ± 4.8 y,b | 15.3 ± 2.9 a | 9.8 ± 1.1 a |
| F | 10.4 ± 1.6 z | 5.8 ± 1.1 z | 7.1 ± 1.5 z,d | 8.8 ± 2.2 a,b,c,d | 35.5 ± 4.5 c | |
| Liver TG (mg/mg protein) | M | 36.6 ± 3.1 y | 30.8 ± 3.1 x | 43.1 ± 3.7 y | 33.1 ± 2.5 | 30.4 ± 4.0 |
| F | 26.8 ± 2.5 y | 23.2 ± 1.5 x | 32.2 ± 1.6 y | 36.8 ± 2.0 | 35.5 ± 4.5 | |
HP1, offspring of high protein (HP) dams re-matched to HP in adulthood; HF1, offspring of high prebiotic fiber (HF) dams re-matched to HF in adulthood; C1, offspring of control dams re-matched to control in adulthood; R, reference group no high fat/sucrose (HFS) consumed; H, continued on HFS after other groups re-matched; M, male; F, female. GIP, glucose-dependent insulinotropic polypeptide; PYY, peptide tyrosine tyrosine; GLP-1, glucagon-like peptide-1; HOMA-IR, homeostasis model assessment of insulin resistance; TG, triglycerides. Values are means ± SEM, n = 10 per group except n = 4 for group H. Values with different letters are significantly different from each other: superscripts x,y,z indicate significant difference between C1, HP1, HF1; superscripts a,b,c,d indicate significant difference between R, H and C1 (p < 0.05).
Figure 4Area under the curve for glucose (A), insulin (B), amylin (C) and leptin (D) over a 90 min oral glucose tolerance test (OGTT) at 28 weeks. Values are means ± SEM, n = 10 per group except n = 4 for group H. Treatments with different letters are significantly different between diets: superscripts x,y indicate significant difference between C1, HP1, HF1; superscripts a,b indicate significant difference between R, H and C1 (p < 0.05).
Figure 5Area under the curve for GLP-1 (A), PYY (B), GIP (C) and ghrelin (D) over a 90 min OGTT at 28 weeks. Values are means ± SEM, n = 10 per group except n = 4 for group H. Treatments with different letters are significantly different between diets: superscripts x,y indicate significant difference between C1, HP1, HF1; superscripts a,b indicate significant difference between R, H and C1 (p < 0.05).
Figure 6Blood glucose concentrations during an oral glucose tolerance test in male (A) and female (B) offspring. Values are means ± SEM, n = 10 per group except n = 4 for group H. There was a significant effect of time (p < 0.05) for males and females.
Hepatic gene expression in the offspring of dams fed a control, high-protein or high-prebiotic fiber diet during pregnancy and lactation and then re-matched to their respective diets in adulthood.
| Diet Group | |||||||
|---|---|---|---|---|---|---|---|
| Sex | HP1 | HF1 | C1 | Diet | Sex | Diet × Sex | |
| SREBP-1c | M | 5.5 ± 0.73 | 2.6 ± 0.7 | 4.6 ± 0.67 | 0.002 | 0.002 | 0.143 |
| F | 4.0 ± 0.66 | 2.1 ± 0.47 | 1.7 ± 0.53 | ||||
| ACC | M | 13.3 ± 2.0 | 10.9 ± 2.0 | 15.0 ± 1.6 | 0.032 | 0.553 | 0.097 |
| F | 18.9 ± 3.1 | 10.6 ± 1.2 | 12.6 ± 1.3 | ||||
| FAS | M | 6.8 ± 2.0 | 4.7 ± 1.1 | 4.0 ± 0.74 | 0.002 | 0.001 | 0.124 |
| F | 18.2 ± 3.1 | 13.0 ± 1.9 | 8.2 ± 0.92 | ||||
| PGC1α | M | 88.9 ± 19.6 y | 45.9 ± 9.8 x | 24.1 ± 5.8 x | 0.001 | 0.064 | 0.972 |
| F | 110.9 ± 21.1 y | 62.5 ± 13.6 x | 45.7 ± 6.4 x | ||||
| Glucose-6-Phosphatase | M | 23.6 ± 5.5 x | 19.5 ± 3.8 x,y | 17.1 ± 2.7 x,y | 0.001 | 0.031 | 0.014 |
| F | 43.6 ± 4.4 y | 16.7 ± 2.9 x | 20.5 ± 2.3 x | ||||
| AMPKα1 | M | 16.5 ± 1.6 | 11.7 ± .9 | 10.7 ± 1.4 | 0.006 | 0.587 | 0.121 |
| F | 16.2 ± 2.8 | 9.7 ± 1.8 | 15.2 ± 1.0 | ||||
C1, offspring of control dams re-matched to control; HP1, offspring of high protein (HP) dams re-matched to HP; HF1, offspring of high prebiotic fibre (HF) dams re-matched to HF; SREBP1c, sterol regulatory element-binding protein-1c; M, male; F, female; ACC, acetyl-CoA carboxylase; FAS, fatty acid synthase; PGC1α, Peroxisome proliferator-activated receptor gamma coactivator-1-alpha; AMPKα1, AMP-activated protein kinase alpha-1. Values are means ± SEM, n = 10 per group except n = 4 for group H. Values with different letters are significantly different from each other (p < 0.05).